Cargando…
Loading, please waitCargando…
Loading, please wait2026 Comparison Guide
An honest, side-by-side look at cost, regulation, available cell types, travel logistics, and when staying in the United States is the better clinical choice. Written for patients weighing a cross-border regenerative-medicine decision.
Cross-border demand
Every year, tens of thousands of US patients cross the border for regenerative medicine. The pattern is consistent: an orthopedic surgeon recommends a partial knee replacement, a neurologist offers only symptom-management for an autoimmune flare, or a hair-restoration consult quotes a five-figure PRP package. The patient does a second pass online, finds that mesenchymal stem cell (MSC) and exosome protocols available at COFEPRIS-regulated clinics in Mexico cost 60–80% less than US cash-pay rates, and starts planning a trip.
Cash-pay rates in the US for an allogeneic UC-MSC infusion routinely run $15,000–$50,000+ when available, while equivalent COFEPRIS-regulated protocols in Cancún are commonly $5,000–$15,000 inclusive of physician fees, lab work, and concierge support.
FDA-approved cellular therapies in the US are limited to a small list (hematopoietic stem cell transplants, a few CAR-T products). Autologous bone-marrow aspirate concentrate (BMAC) is generally the only orthopedic option; allogeneic umbilical-cord MSCs and culture-expanded MSCs sit in a gray zone or are explicitly prohibited for general use.
Cancún International Airport (CUN) sees direct flights from over 30 US cities (Miami, Dallas, Houston, New York/JFK, Chicago, Atlanta, LA, Denver, Charlotte and more). Average flight time from the US East Coast is 2.5–3.5 hours; from the West Coast 4–5 hours. No layover required for most patients.
Combining treatment with a Caribbean recovery week — quiet beach hotels, warm climate, low logistical stress — is a meaningful clinical advantage compared with flying back home the same day to navigate US logistics.
Regulatory frameworks
Both agencies enforce strict standards, but they categorize regenerative medicine differently. Understanding the distinction is essential before you choose where to be treated.
Important: Important: 'less FDA oversight' does not mean 'less safety oversight' — it means a different regulatory model. The risk patients should worry about is not Mexico vs the US, but rather licensed vs unlicensed clinics in either country.
Cost comparison
Typical 2026 USD price ranges from published clinic menus and patient-reported invoices. US figures assume cash-pay; insurance reimbursement for regenerative medicine is uncommon in either country. Mexico figures reflect COFEPRIS-regulated clinics in major medical-tourism cities (Cancún, Tijuana, Guadalajara, Monterrey).
| Indication / protocol | USA (cash-pay) | Mexico (COFEPRIS) |
|---|---|---|
| Knee osteoarthritis — single intra-articular MSC injection | $5,000 – $12,000 | $2,500 – $5,500 |
| Knee MSC — full 3-injection series with imaging | $15,000 – $30,000 | $5,500 – $10,000 |
| Spine / disc degeneration — fluoroscopy-guided MSC injection | $8,000 – $20,000 | $3,500 – $8,000 |
| Autoimmune / chronic inflammation — IV UC-MSC infusion (per session) | Generally not offered / trial-only | $5,000 – $9,500 |
| Anti-aging / systemic IV MSC protocol | $15,000 – $50,000+ | $7,500 – $15,000 |
| Hair restoration — PRP + exosomes (full course) | $3,000 – $8,000 | $1,500 – $4,500 |
All figures in USD. Mexico ranges include physician fees, in-clinic lab work, and basic concierge; international travel, hotel, and follow-up labs are additional. Pricing varies by clinic, cell dose, and number of sessions — always request a written quote on clinic letterhead.
Therapeutic options
The biggest practical difference between the two countries is not safety or sophistication — it's the menu of therapies a patient can legally receive.
Travel logistics
Cancún International Airport (CUN) is the busiest international gateway in Mexico for US medical tourism. Direct service from major US hubs, English-speaking clinic staff, and a relatively short stay (3–5 days for most protocols) make the trip logistically manageable even for patients with limited mobility.
| US departure city | Direct flight time to CUN | Daily carriers (typical) |
|---|---|---|
| Miami (MIA) | 1h 30m | American, JetBlue, Spirit, Frontier |
| Dallas/Fort Worth (DFW) | 2h 20m | American, Spirit, Aeroméxico |
| Houston (IAH) | 2h 25m | United, Spirit |
| Atlanta (ATL) | 2h 50m | Delta, Spirit, Frontier |
| New York (JFK) | 3h 50m | Delta, JetBlue, American |
| Chicago (ORD) | 3h 55m | American, United, Spirit |
| Los Angeles (LAX) | 4h 45m | Alaska, American, Delta |
| Denver (DEN) | 4h 10m | United, Frontier, Southwest |
No visa is required for US, Canadian, UK, or EU citizens for stays under 180 days. A valid passport is the only legal requirement; bring a printed Mexican Tourist Card (FMM) which you receive in-flight or at the kiosk.
A typical treatment trip to Regeneris Therapy in Cancún spans 3 to 5 days. Day 1 is arrival, hydration, and a full physician evaluation. Day 2 is in-clinic protocol delivery (cell preparation, infusion or injection, monitoring). Days 3–4 are recovery — light walking, hydration, and avoiding sun or alcohol per discharge instructions. Day 5 is a follow-up check before flying home. Partner hotels in Puerto Cancún and the Hotel Zone offer medical-tourism rates and are 5 to 15 minutes from the clinic by private transfer.
Quality & accreditation
Cross-border care only works when the clinic is genuinely licensed and accountable. Before booking any stem cell protocol — in Mexico, the US, Costa Rica, Panama, or anywhere else — confirm the following.
Every Mexican clinic that legally offers cellular therapy must have a published Aviso Sanitario number. Search it on the COFEPRIS portal. Regeneris Therapy publishes both its health notice (2323025036X00098) and advertising notice (2323022002A00053).
Every treating physician in Mexico must hold a cédula profesional issued by the SEP (Secretaría de Educación Pública). It is publicly verifiable at cedulaprofesional.sep.gob.mx. Specialists hold an additional cédula de especialidad.
The International Society for Cell & Gene Therapy (ISCT) and International Society of Blood Transfusion (ISBT) publish minimal-criteria standards for MSC characterization, viability, sterility, and labeling. Reputable cell banks document compliance and provide a Certificate of Analysis (COA) per batch.
For allogeneic protocols, ask for the cell-bank name, donor-screening protocols, viability percentage, passage number, and the COA for your specific batch. Refuse any clinic that cannot or will not produce these documents.
Mexican specialty clinics carry professional liability insurance and operate under the Ley General de Salud. Ask for written confirmation of malpractice coverage and a complaint procedure.
You should receive a written informed consent in your native language detailing the cell source, dose, expected outcomes, alternative treatments, and known risks. Anything less is a red flag.
Honest counter-cases
We are a Mexican clinic — but recommending a trip abroad for every patient is bad medicine. There are legitimate scenarios where US-based care is the clinically better choice. Be honest with yourself about whether any of these apply.
If you are Medicare-eligible and your orthopedic surgeon confirms bone-on-bone Grade IV osteoarthritis with mechanical locking, a covered partial or total joint replacement may give better long-term outcomes than any regenerative protocol. Stem cells work best for moderate (Grade II–III) disease before joint surface collapse.
Patients on active immunosuppressive therapy, recent organ transplant recipients, or those with active or recently-treated malignancy require multidisciplinary oversight that is harder to coordinate across borders. US-based clinical-trial enrollment (NCT-registered, IRB-approved) is generally safer for these populations.
For specific conditions (hematologic malignancies treatable with HSCT, certain B-cell lymphomas treatable with CAR-T, ALS qualifying for approved cell therapy), the FDA-approved US pathway is the standard of care. Going abroad for an unapproved version of an approved therapy is rarely the right call.
Advanced cardiopulmonary disease, severe spinal instability, recent major surgery, or active infection are contraindications to flying. If you cannot travel safely, a local US autologous protocol (BMAC, PRP) is better than no treatment.
Rarely, US insurance does cover certain MSC or PRP indications (some workers' comp, sports-medicine carve-outs). If you have actual coverage and a participating provider, use it.
Decision framework
A practical 5-question decision framework for patients weighing US vs Mexico for stem cell therapy.
Get a written second opinion. Is your problem a structural failure (torn ligament, advanced arthritis, ruptured disc) or a degenerative-inflammatory process (early-stage arthritis, tendinopathy, autoimmune flare, hair thinning, age-related dysfunction)? Stem cells help most with the second category.
If yes, exhaust that pathway first. If no, regenerative options become reasonable to evaluate seriously — in either country.
If your protocol calls for autologous BMAC or PRP, you can get those in either country. If it calls for allogeneic UC-MSCs, culture-expanded MSCs, or exosomes at therapeutic dose, you'll likely need to travel.
COFEPRIS Aviso Sanitario, cédula profesional for every treating physician, ISCT-compliant cell bank, written informed consent in your language. If any are missing, walk away.
Direct flight, 3–5 day stay, follow-up plan back home. If yes — Mexico is a legitimate option with significant cost and protocol-availability advantages. If no — focus on what you can access safely.
FAQ
The eight questions patients ask us most often when weighing stem cell therapy in Mexico vs the USA.
Stem cell therapy at a COFEPRIS-licensed clinic with cédula-verified physicians, ISCT-aligned cell-bank sourcing, and documented informed consent has a safety profile comparable to equivalent US clinical-trial protocols. The risk is not country-based — it is clinic-based. Always verify the Aviso Sanitario number on the COFEPRIS portal before booking, and refuse any clinic that cannot produce a Certificate of Analysis (COA) for your cell batch.
The cost gap reflects three structural differences: (1) Mexican healthcare costs are 40–70% lower across the board (real estate, salaries, malpractice insurance, lab reagents), (2) the COFEPRIS regulatory framework allows protocols that in the US would require expensive Phase III clinical trial enrollment, and (3) the medical-tourism market is competitive, so clinics price for the international cash-pay patient rather than US insurance contracts. Lower price does NOT mean lower quality at a licensed clinic.
The FDA has signaled increased openness to cell-based therapies and has approved a handful of products (HSCT for blood cancers, CAR-T for specific lymphomas, Stratagraft for burns). However, broad approval of allogeneic MSC infusions for orthopedic, autoimmune, or anti-aging indications is unlikely before 2028–2030 based on current Phase II/III trial timelines. Patients seeking these protocols in the meantime largely travel abroad.
Most US private insurers do not reimburse regenerative medicine abroad, but a small number do for specific orthopedic indications. Bring your itemized Mexican invoice (which clinics like Regeneris provide) when filing a claim, and ask about HSA/FSA eligibility — IRS Publication 502 generally allows qualified medical expenses abroad if performed by a licensed practitioner. Always confirm with your specific carrier before booking.
Most protocols require 3 to 5 days on the ground. A typical schedule is: Day 1 arrival and physician evaluation, Day 2 cell preparation and administration, Days 3–4 recovery and monitoring, Day 5 follow-up before departure. Patients receiving multi-session protocols (e.g., 3-injection knee series spaced 4–6 weeks apart) may either return for each session or have follow-up doses shipped to a US partner clinic.
Autologous means your own cells — drawn from your bone marrow or fat, processed, and re-administered the same day. Allogeneic means donor-derived cells — typically from screened umbilical cord tissue, expanded in a licensed cell bank to a standardized dose. Autologous is what's mostly available in the US under minimal-manipulation rules. Allogeneic UC-MSCs are more potent (younger, more proliferative cells) and dose-controlled, but require a licensed cell bank — and are why most patients seeking these protocols travel to Mexico.
Five verifiable signals: (1) Published COFEPRIS Aviso Sanitario number that you can confirm on the COFEPRIS portal, (2) Cédula profesional for every treating physician, verifiable at cedulaprofesional.sep.gob.mx, (3) Named, accredited cell-bank source with a Certificate of Analysis per batch, (4) Written informed consent in your language detailing cell type, dose, and risks, (5) Transparent written quote on clinic letterhead. Regeneris Therapy meets all five and publishes documentation on its team and credentials pages.
Common indications at COFEPRIS-regulated clinics include knee, hip, shoulder, and spine osteoarthritis (Grades II–III); chronic tendon and ligament injury; degenerative disc disease; autoimmune and chronic-inflammatory conditions (Crohn's, rheumatoid arthritis, MS — adjunct to medical management); chronic post-COVID inflammation; sexual wellness and erectile dysfunction; hair restoration; and systemic anti-aging protocols. Each protocol requires a physician evaluation — stem cells are not universally indicated, and a reputable clinic will tell you when they are not the right answer for your condition.
Continue exploring
The full overview of stem cell therapy at Regeneris Therapy: cell sources, protocols, and how to start.
ContinueA deep dive into the safety record, COFEPRIS regulation, and red flags to watch for.
ContinueConcierge, airport pickup, partner hotels, bilingual support — every detail of your Cancún visit.
ContinueTransparent USD pricing for our most common regenerative medicine protocols.
ContinueStart with a 60-minute physician evaluation — virtual or in-clinic.
ContinueDr. Claudia Labastida and our cédula-verified physicians and biotechnologists.
ContinueThe full long-form guide to planning a medical trip to Cancún, beyond stem cell therapy.
ContinueThis page is informational and does not constitute medical advice. Regenerative medicine outcomes vary by patient, condition severity, and cell type. Stem cell therapy is not FDA-approved for most indications discussed here, and most US insurance plans do not reimburse it. Always seek an in-person evaluation with a licensed physician before deciding on a treatment plan, and disclose all current medications and conditions. Regeneris Therapy operates under COFEPRIS Aviso Sanitario 2323025036X00098 and Aviso de Publicidad 2323022002A00053 in Cancún, Mexico.
Book a free 15-min call with our team.
Send your imaging and recent labs. Within 1–2 business days, one of our physicians will email you a written assessment of whether your case is a fit, with a transparent written quote in USD if it is.